Pharmacokinetics Assessing Bioavailability of Gingerols and Shogaols of Five Ginger Extracts

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 15, 2018

Primary Completion Date

December 7, 2018

Study Completion Date

December 7, 2018

Conditions
Healthy Subject
Interventions
DIETARY_SUPPLEMENT

Tested product n°1

1 capsule (26% of gingerol/shogaol in 100 mg) to consume one time for each subject, at one experimental session (random assignment), with 250 mL of water (consumption at T0 time-point of the kinetic)

DIETARY_SUPPLEMENT

Tested product n°2

1 capsule (38.6% of gingerol/shogaol in 74.9 mg) to consume one time for each subject, at one experimental session (random assignment), with 250 mL of water (consumption at T0 time-point of the kinetic)

DIETARY_SUPPLEMENT

Tested product n°3

2 capsules (6.8% of gingerol/shogaol in 424.3 mg) to consume one time for each subject, at one experimental session (random assignment), with 250 mL of water (consumption at T0 time-point of the kinetic)

DIETARY_SUPPLEMENT

Tested product n°4

1 capsule (27% of gingerol/shogaol in 104.9 mg) to consume one time for each subject, at one experimental session (random assignment), with 250 mL of water (consumption at T0 time-point of the kinetic)

DIETARY_SUPPLEMENT

Tested product n°5

6 capsules (1.6% of gingerol/shogaol in 1806.25 mg) to consume one time for each subject, at one experimental session (random assignment), with 250 mL of water (consumption at T0 time-point of the kinetic)

Trial Locations (1)

44800

Biofortis Mérieux Nutrisciences, Saint-Herblain

All Listed Sponsors
collaborator

Biofortis Mérieux NutriSciences

OTHER

lead

Givaudan France Naturals

INDUSTRY

NCT03698318 - Pharmacokinetics Assessing Bioavailability of Gingerols and Shogaols of Five Ginger Extracts | Biotech Hunter | Biotech Hunter